Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Download features.
Download gene features.
Dog (Canis lupus familiaris) is a subspecies of gray wolf (Canis lupus)
Taxonomy ID: 9615
Canis lupus familiaris isolate BM31197 large subunit ribosomal RNA gene, partial sequence; mitochondrial
497 bp linear DNA
Taxonomy
JP 2019521176-A/26: COMPOSITIONS AND METHODS FOR TREATMENT OF MUSCULAR DYSTROPHY
21 bp linear
JP 2019521176-A/22: COMPOSITIONS AND METHODS FOR TREATMENT OF MUSCULAR DYSTROPHY
22 bp linear
JP 2019521176-A/15: COMPOSITIONS AND METHODS FOR TREATMENT OF MUSCULAR DYSTROPHY
JP 2019520391-A/771: CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIONS
229 bp linear DNA
JP 2019536056-A/5: APPARATUS AND METHOD FOR DETECTING CANINE CANCER
1,053 bp linear DNA
JP 2019536056-A/4: APPARATUS AND METHOD FOR DETECTING CANINE CANCER
19 bp linear DNA
JP 2019536056-A/3: APPARATUS AND METHOD FOR DETECTING CANINE CANCER
18 bp linear DNA
JP 2019536056-A/2: APPARATUS AND METHOD FOR DETECTING CANINE CANCER
37 bp linear DNA
JP 2019536056-A/1: APPARATUS AND METHOD FOR DETECTING CANINE CANCER
34 bp linear DNA
JP 2019520078-A/73: COMPOSITIONS AND METHODS COMPRISING IMPROVEMENTS OF CRISPR GUIDE RNAS USING THE H1 PROMOTER
JP 2021511803-A/833: COMPOSITIONS AND METHODS FOR CORRECTING DYSTROPHIN MUTATIONS IN HUMAN CARDIOMYOCYTES
20 bp linear DNA
JP 2020522480-A/1: A METHOD TO CREATE PERSONALIZED CANINE CANCER VACCINES
39 bp linear DNA
JP 2020522477-A/9: UNIVERSAL CANCER VACCINES AND METHODS OF MAKING AND USING SAME
Chain 1, SRP RNA
249 bp linear other
PubMed Taxonomy
JP 2020519660-A/7: COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
1,889 bp linear DNA
JP 2020519660-A/6: COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
3,229 bp linear DNA
JP 2020522479-A/1: A METHOD TO CREATE PERSONALIZED CANCER VACCINES
JP 2020517720-A/20: THERAPEUTIC FORMULATIONS CONTAINING CD34+ STEM CELLS DERIVED FROM NEGATIVE SELECTION
1,114 bp linear DNA
JP 2019530433-A/12: MG53 Mutants, Methods of Making the Same, and Uses Thereof
1,434 bp linear DNA
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on